Overview
- 5 FDA inspections are on record.
- 5 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-04-09.
At a glance
Inspections
5
Form 483s
5
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 6 Apr 2026 – 9 Apr 2026 | Human Drugs | 483 | View 483 → |
| 14 Apr 2025 – 25 Apr 2025 | Human Drugs | 483 | View 483 → |
| 1 Dec 2020 – 28 Jan 2021 | Human Drugs | 483 | View 483 → |
| 16 Apr 2018 – 27 Apr 2018 | Human Drugs | 483 | View 483 → |
| 12 Sep 2016 – 20 Oct 2016 | Human Drugs | 483 | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
25 Apr 2025
21 CFR 211.160(b)
Scientifically sound laboratory controls
Cited by Sangeeta M Khurana, Dogbeda F Mackenzie
25 Apr 2025
21 CFR 211.167(c)
Controlled release dosage form testing
Cited by Sangeeta M Khurana, Dogbeda F Mackenzie
25 Apr 2025
21 CFR 211.94(b)
Protection from external factors
Cited by Sangeeta M Khurana, Dogbeda F Mackenzie
Investigators
FDA investigators tied to this site in the record.
June P Page3 insp.
Demario L Walls1 insp.
Sangeeta M Khurana1 insp.
Dogbeda F Mackenzie1 insp.
Julius I Jones1 insp.
Pallavi K Lele1 insp.
Abby L Mozeke-Baker1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.22(c) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.42(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.110(a)(3) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(b)(4) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.167(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.198(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.198(b)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.25(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(iv) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(v) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.94(b) | Cited across public-safe Form 483 observations | 1x |
| FDCA 503B(a)(10)(A) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Wells Pharmacy, Inc's 5 Form 483s
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat